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Background: Frameless immobilization allows for planning and quality assurance of intensity-modulated
radiosurgery (IM-SRS) plans. We tested the hypothesis that IM-SRS planning with uniform tissue density corrections
results in dose inaccuracy compared to heterogeneity-corrected algorithms.
Methods: Fifteen patients with tumors of the pituitary or cavernous sinus underwent frameless IM-SRS. Treatment
planning CT and MRI scans were obtained and fused to delineate the tumor, optic nerves, chiasm, and brainstem.
The plan was developed with static gantry IM-SRS fields using a pencil beam (PB), analytical anisotropic (AAA), and
Acuros XB (AXB) algorithms. We evaluated measures of target coverage as well as doses to organs at risk (OAR) for
each algorithm. We compared the results of each algorithm in the cases where PTV overlapped OAR (n = 10) to
cases without overlapping OAR with PTV (n = 5). Utilizing film dosimetry, we measured the dose distribution for
each algorithm through a uniform density target to a rando phantom with non-uniform density of air, tissue, and
bone.
Results: There was no difference in target coverage measured by DMaxPTV, DMinPTV, D95%PTV, or the isodose surface (IDS)
covering 95 % of the PTV regardless of algorithm. However, there were differences in dose to OAR. PB predicted higher
(p < 0.05) Dmax for the brainstem, chiasm, right optic nerve, and left optic nerve. In cases of PTV overlapping an optic
nerve (n = 7), PB was unable to limit dose to 8Gy while achieving PTV coverage (PB 855 cGy vs. AAA 769 cGy, p = 0.05
vs. AXB 658 cGy, p = 0.03). Within the rando phantom, the PB and AAA algorithms over-estimated the dose delivered in
the bone-tissue-air interface of the sinus (+17 %), while the AXB algorithm closely predicted the actual dose delivered
through the inhomogeneous tissue (+/- 1 % max, p < 0.05).
Conclusions: Patients undergoing frameless SRS benefit from heterogeneity corrected dose plans when the lesion lies
in areas of widely varying tissue density and near critical normal structures such as the skull base. Film dosimetry
confirms that the AXB dose calculation algorithm more accurately predicts actual dose delivered though tissues of
varying densities than PB or AAA dose calculation algorithms.
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Radiosurgery plays an important role in the treatment of
both benign and malignant intracranial neoplasms [1, 2].
Linear accelerator (LINAC) radiosurgery has proven effi-
cacious in utilizing a frame-based concept of treating
these tumors [3, 4]. The patient is required to wear a
rigid head frame to ensure immobilization and position-
ing, which limits the time allowed for radiation and
planning quality assurance (QA). A frameless device has
been developed for intracranial radiosurgery which
avoids patient discomfort associated with the rigid head
frame [5, 6]. It has been proven to have clinical feasibil-
ity and accuracy compared to frame-based systems when
used in conjunction with image guidance [6, 7]. Frame-
less immobilization allows for planning and quality as-
surance of complicated intensity-modulated radiosurgery
(IM-SRS) plans, which would be predicted to improve
target dose while minimizing critical tissue doses.
Dose gradients and tissue inhomogeneity effects
should be considered during the entire process of
intensity-modulated radiotherapy (IMRT) planning [8].
Lesions near the pituitary fossa and cavernous sinus
benefit from IM-SRS because the generated steep dose
gradient allows tumoricidal doses while sparing the
optic nerves and chiasm. Treatment of this location,
however, poses IM-SRS planning difficulties due to the
variation of electron density ranging from bone to tis-
sue to air. Failure to accurately account for the tissue
heterogeneity could result in dose inaccuracies leading
to either toxicity or decreased tumor control.
In the traditional radiosurgery environment where
solitary cranial metastases are treated with cones, con-
formal beams, or dynamic conformal arcs, the issue of
tissue inhomogeneity is mostly irrelevant due to the uni-
formity of the cranial tissue inside the skull. In this uni-
form environment the robustness of tissue corrections
becomes irrelevant and the extended calculation times
which accompany the complexity of the algorithms
employing them become unnecessary. For this reason,
fast and simple algorithms which use somewhat rudi-
mentary heterogeneity corrections, or no such correc-
tions at all, have continued to have relevance in cranial
radiosurgery treatment planning.
The pencil beam (PB) algorithm is the primary method
utilized in routine clinical treatment planning for proton
radiotherapy as it is reasonably accurate and fast [8, 9].
It has not been validated for use in highly inhomogen-
eous areas. PB algorithms have long been in place for all
types of radiation therapy treatment planning. The
Analytical Anisotropic Algorithm (AAA) is a convolution-
superposition-based photon-beam dose computation
algorithm which is fast and more accurate for IMRT than
PB [10, 11]. More recently, complex algorithms employing
robust corrections for tissue inhomogeneities havebecome available. These algorithms have become widely
used in many treatment applications, yet the simpler algo-
rithms have persisted in the radiosurgery environment.
Acuros XB (AXB) is a photon dose calculation algorithm
and is the most recently developed. Of the three algo-
rithms, AXB is the most valid and accurate when applied
to inhomogeneous media [12].
Radiation therapy dose calculation algorithms typically
compute dose to water. Recent algorithms, like AXB
(Varian Medical Systems, Palo Alto, CA) which attempt
to improve accuracy in dose calculations in heteroge-
neous media, offer either absorbed dose to water [D(w)]
or absorbed dose to the material [D(m)] [13]. Neglecting
to take into account differences between D(m) and D(w)
in a heterogeneous environment will lead to systematic
dose errors [13]. Differences between these two methods
have been reported to exceed 10 % for electron beams
[14], and the dose to the bone was larger by up to 10 %
when calculating D(w) instead of D(m) for phantoms and
head and neck patients [14].
We tested the hypothesis that frameless IM-SRS plan-
ning in pituitary and cavernous sinus tumors with uni-
form tissue density corrections results in dose
inaccuracy compared to algorithms accounting for tissue
heterogeneity. The accuracy of the divergent heterogen-
eity corrections was evaluated with film dosimetry. This
manuscript analyzes the consequences of using different
calculation algorithms for the final dose calculation of a
modulated treatment plan optimized based on fluence
calculation with PB. Because we found differences be-
tween the three calculation algorithms, we measured the
dose deposited in a phantom modeling real treatment
conditions.Methods
A total of 15 patients with tumors near air/bone/brain
interfaces, specifically, of the pituitary or cavernous
sinus underwent frameless IM-SRS. The institutional
IRB approved the retrospective study of these cases.
Treatment planning CT (0.6 mm slices) and MRI
(1.0 mm slices) scans were obtained and fused in order
to delineate the tumor as well as the optic nerves, chi-
asm, and brainstem by the treating radiation oncologist
and neurosurgeon. The initial plan was developed with
static gantry IM-SRS fields, and volume dose was calcu-
lated using a PB algorithm (D(w)). Volume dose was
then recalculated with identical monitor units and mlc
movement patterns with AAA (D(w)) and AXB (D(m))
algorithms. We evaluated measures of target coverage
as well as doses to OAR for each algorithm. We also
compared the results of each algorithm in the cases
where PTV overlapped OAR (n = 10) and when there
were no overlapping OAR with PTV (n = 5).
Fig. 1 a Maximum brainstem dose for all cases (n = 15). b Maximum
chiasm and optic nerve doses for single fraction SRS cases (n = 10).
c Maximum optic nerve dose in cases with PTV overlap (n = 7).
* indicates p < 0.05 for all figures between PB and the
designated algorithm
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the predicted dose distribution for each algorithm in
solid water as well as through tissue to bone to air
within a rando phantom. Using a NovalisTX linear accel-
erator, a single 6MV photon beam delivering 12Gy was
exposed through gafchromicXB2 film on a solid water
phantom and through the sinus of a rando phantom.
Commissioning each algorithm requires independent
sets of data for the purpose of beam modeling. The au-
thors addressed the uncertainty introduced by the differ-
ences in collecting and processing of the base data by
separating the film dosimetry validation into two steps.
The uniformity and simplified geometry of the solid
water phantom was used to verify the congruence of the
dose prediction between algorithms without the compli-
cations of heterogeneity [15]. A film was placed between
slabs of solid water and arranged perpendicular to the
beam incidence. This test was designed to demonstrate
consistency of data collection and commissioning be-
tween algorithms. Blank films were subtracted from the
irradiated film with consideration to the orientation of
the film on the scanner. A film calibration file was ap-
plied to convert optical density to dose. The film was
compared to dose planes and profiles predicted by each
of the algorithms, and consistency in the beam data be-
tween algorithms was confirmed.
We compared the predicted measures of dose to the
PTV and OAR using a two-tailed Student’s t-test be-
tween PB and AAA or AXB as well as the measured film
dose in the rando phantom between the algorithms.
Results
All cases
The initial analysis consisted of both single and five
fraction cases (n = 15). We found there was no differ-
ence in target coverage between PB, AAA, or AXB.
There was no difference in DMaxPTV between PB
(115 % ± 14 %), AAA (113 % ± 13 %), or AXB (116 % ±
14 %). In addition, DMinPTV was no different for each
algorithm (PB [73 % ± 20 %], AAA [71 % ± 21 %], AXB
[73 % ± 19 %]), and D95%PTV was no different for each
algorithm (PB [94 % ± 12 %], AAA [93 % ± 11 %], AXB
[92 % ± 12 %]). The IDS covering 95 % of the PTV was
no different for each algorithm (PB [81 % ± 35 %, AAA
[93 % ± 11 %], AXB [83 % ± 34 %]). The maximum
brainstem dose was higher for PB (916 ± 685 cGy) com-
pared to AAA (850 ± 645 cGy, p = 0.004 vs PB) and
AXB (851 ± 659 cGy, p = 0.002 vs PB) (Fig. 1a).
Single fraction radiosurgery cases
The analysis was then limited to single fraction cases
(n = 10) as the accepted maximum dose to the chiasm
and optic nerves was 8 Gy [16]. For these cases, the
pass rate was evaluated relative to the 8Gy tolerancedose to the optic nerves. Calculations predicting max-
imum doses below 8Gy to both optic nerves were con-
sidered passing with respect to this criterion. As in
other areas of this study, optimized fluence was held
constant and volume dose was compared between PB,
AAA, and AXB with pass rates of 40, 50, and 60 %
respectively.
PB predicted a statistically significant higher maximum
dose than either AAA or AXB to the chiasm (771 ±
255 cGy vs 666 ± 228 cGy [p = 0.0004 vs PB] vs 693 ±
229 cGy [p = 0.001 vs PB]); the right optic nerve (715 ±
231 cGy vs 602 ± 233 [p = 0.01 vs PB] vs 547 ± 255 cGy
[p = 0.01 vs PB]); and left optic nerve (762 ± 288 cGy vs
685 ± 305 cGy [p = 0.02 vs PB] vs 673 ± 299 cGy [p =
0.01 vs PB]) (Fig. 1b).
Organs at risk
In order to determine the influence of heterogeneity
correction in the areas of maximum dose gradients, we
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PTV and OAR overlapped (n = 10) compared to the
cases without overlap (n = 5). For the 10 cases with
overlap, there were 22 total overlapping structures, ran-
ging from 1-3 per case. The right optic nerve over-
lapped in all ten cases, while the left optic nerve andFig. 2 a Rando Man® phantom irradiated with an anterior oblique beam th
cavity by PB algorithm. c Dose Volume Histogram (DVH) comparing dose t
AAA algorithm. e DVH comparing dose to structure in air by PB versus AXBchiasm overlapped in six cases, respectively. Since the
maximum tolerated dose was well established for single
fraction radiosurgery, we compared the maximum
doses to the optic nerve for the overlap (n = 7) and
non-overlapping (n = 4) cases that received a single
fraction. In cases of PTV overlapping an optic nerverough the sinus cavity. b Predicted isodose distribution through sinus
o structure in air for PB versus AAA. d Predicted isodose distribution by
. f Predicted isodose distribution by AXB algorithm
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dicted while achieving PTV coverage (PB 855 ± 179 cGy
vs. AAA 769 ± 203 cGy, p = 0.05 vs. AXB 658 ±
270 cGy, p = 0.03) (Fig. 1c).Phantom film measurements
Given the differences in prediction for the three algo-
rithms found above, we sought to determine the abso-
lute delivered dose for both uniform and heterogeneous
density materials. The Rando Man® phantom from The
Phantom Laboratory was used to test the dose predic-
tion near heterogeneities [17]. The phantom was irradi-
ated with an anterior oblique beam through the sinus
cavity (Fig. 2a), with a path through several interfaces
between air, soft tissue, and bone. The calculated dose in
the phantom with PB, AAA, and AXB algorithms is
shown in Fig. 2 (Fig. 2b-f ). Within the solid water phan-
tom, the PB, AAA, and AXB algorithms each accurately
predicted the delivered dose (+/- 1 % max) (Fig. 3a). The
dose measured with GAFCHROMIC® film in the Rando
compared to the dose predicted by PB, AAA, and AXB
algorithms (Fig. 3b). Within the Rando Man® phantom,
the PB and AAA algorithms predicted an overestimationFig 3 a Dose profile in solid water phantom compared with predicted dos
target from Fig. 2. c Horizontal dose profile from Fig. 3b compared with pr
Fig. 3b compared with predicted dose from AXB, AAA, and PB. * indicatesof the dose delivered in the bone-tissue-air interface of
the sinus (+17 %), while the AXB algorithm closely pre-
dicted the actual dose delivered through the inhomogen-
eous tissue (+/- 1 % max, P <0.05) (Fig. 3c,d).Discussion
In this study of 15 patients with tumors of the pituitary
or cavernous sinus, we investigated whether frameless
IM-SRS planning with uniform tissue density corrections
results in dose inaccuracy compared to algorithms ac-
counting for tissue heterogeneity. We found that, in gen-
eral, there was no difference in target coverage for cases
that were in the cavernous sinus or pituitary fossa re-
gardless of algorithm used. However, the maximum
brainstem dose was higher for PB compared to AAA
and AXB, suggesting that uniform density calculations
could alter dose to critical OAR. Based on these initial
findings, we sought to identify the clinical situations
where heterogeneity corrections were essential.
Since the dose limits to the optic nerves and chiasm
are well-established for single fraction radiosurgery, we
also investigated the relationship between the location of
the tumor and dose limits in single fraction cases. Theree from AXB, AAA, and PB. b Film exposure after irradiation of sinus
edicted dose from AXB, AAA, and PB. d Vertical dose profile from
p < 0.05 for all figures between AXB and both PB and AAA
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15-21Gy and a mean of 17.3Gy. PB predicted a statisti-
cally significant higher maximum dose than either AAA
or AXB to the chiasm and the optic nerves bilaterally.
Therefore, the use of a uniform density algorithm in
these cases predicted a higher risk of OAR toxicity.
Finally, we investigated the influence of density cor-
rection algorithms when IMRT optimization would be
most complex, specifically, when OAR and PTV over-
lap. All three algorithms did not influence optimization
to protect OAR as there was significantly lower mini-
mum dose to the PTV with OAR overlap versus cases
without OAR overlap. However, PB predicted a Dmax
above 8Gy to the optic nerves for similar target cover-
age compared with either heterogeneity-corrected algo-
rithm. The AAA dose to the optic nerves was near 8Gy
at 7.69Gy for the overlap cases while AXB was less at
6.6Gy. We observed across all three analyses that PB
consistently predicted a higher dose to OAR for similar
target coverage. Given that clinical toxicity ultimately
occurs as a result of deposited dose, we investigated
which of the algorithms accurately predicted dose in
uniform and hetereogeneous density phantoms.
After irradiation of a solid water or rando phantom,
we measured the deposited dose using film. All three al-
gorithms accurately predicted the dose in the solid water
phantom. The rando phantom exemplifies a unique
model of bone-tissue-air interface of the sinus and was
used to compare the predicted dose as discerned by each
algorithm to the measured dose for a target near several
interfaces across varying densities. Within the rando
phantom, the PB and AAA algorithms predicted an
overestimation of the dose delivered in the bone-tissue-
air interface of the sinus, while the AXB algorithm
closely predicted the actual dose delivered through the
inhomogeneous tissue. These results taken together sug-
gest that AXB would most accurately predict dose de-
position in patients, and PB would falsely predict
toxicity due to overestimation of dose to OAR. This
work expands upon previous observations made using
density-correction in dose calculation.
PB algorithms employ pencil beam kernels to predict
the distribution of dose from a very narrow beam or
beamlet. A treated beam is divided into several such nar-
row beamlets and the calculated dose to a voxel is the
sum of the dose delivered per beamlet. The kernel de-
fines the spatial distribution of energy following interac-
tions in water. To account for heterogeneities, the
Brainlab PB algorithm adjusts the depth used for dose
calculation to a radiological path length, or a depth of
water equivalent to the depth in tissue when accounting
for differences in attenuation coefficients. There is no
such radiological path length correction applied to the
spatial parameters of the kernel. When heterogeneitieslie in the volume of tissue immediately surrounding the
voxel of interest, the effect of such heterogeneities is not
considered. In the case of AAA, the option to use het-
erogeneous calculations includes a scaling of the scatter
kernels according to the radiological depth. This ac-
counts for effects of the heterogeneities in the area sur-
rounding a voxel of interest.
The AAA [10, 11, 18] was implemented in the Eclipse
treatment planning system (Varian Medical Systems,
Palo Alto, CA) to replace the PB algorithm [8, 9] for cal-
culating dose distributions for photon beams. The goal
of the AAA was to enhance the accuracy of dose calcula-
tions in heterogeneous media. The newer AXB repre-
sents a photon dose calculation algorithm which is
implemented in the Eclipse treatment planning system
[12]. AXB appears to offer a valid and accurate alterna-
tive to Monte Carlo calculations for heterogeneity calcu-
lations [12].
Algorithms which account for tissue heterogeneity do
so with varying degrees of complexity and accuracy. PB
has been the longstanding algorithm of choice in radio-
surgery applications with a very simple method of cor-
recting for differences in electron density. The simplified
method allows for fast calculation times, and in many
intracranial applications produces congruent results in
comparison to the more complex and rigorous hetero-
geneity corrections in algorithms like AAA and AXB.
However, in areas of complex geometric heterogeneities,
the predictions of the respective algorithms diverge.
Radiosurgery dose constraints for OAR are based on
clinically observed adverse events, which often take
months or years to become apparent. The dose for the
optic structures of 8Gy appears to be conservative and
based on CT-only based planning. Incorporation of MRI
guidance for SRS resulted in a tolerance of 10Gy, but
only with cases without tumor overlapping the PTV
[19]. Therefore, as technology of SRS has evolved, so
have the OAR dose tolerances. However, due to the tim-
ing of the late effects, there is a lag of understanding of
the clinical implications of the implemented technology.
We have observed that for the same PTV dose, AAA
and AXB both predict lower doses to the optic nerves
and chiasm (Fig. 1b and c) ranging from 10 to 13 %. Our
phantom measurements confirm AXB models the dose
to these tissues more accurately than PB. This may mean
that the actual tolerance of the optic structures is 10 %
less than the 10Gy observed above with PB algorithms,
at 9Gy. Additional follow-up of patients treated with
AXB is necessary to confirm.
The present work relied on initial optimization of flu-
ence of beamlets using a simplified DVO algorithm for
calculation speed. Subsequent dose calculation was done
with PB, AAA, or AXB on the DVO fluence. Given the
disparity of calculated and measured dose from PB, AAA,
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ing heterogeneity-corrected optimization of four uniform
patients each with PTV overlapping the right optic nerve
and a prescription dose of 15Gy. AAA and AXB were both
used for the intermediate dose calculation. Automated
optimization was performed which included optimization
with DVO, dose calculation with the specified volume
dose calculation algorithm, and repeated optimization
utilizing the dose calculation information as input for the
subsequent optimization. Maximum dose to the optic
nerves for PB optimized and calculated plans was
853 cGy compared to 663 with AAA optimized and
calculated plans (p = 0.02). The maximum optic nerve
dose with AXB optimized and calculated plans was
685 cGy (p = 0.02). Although statistically significant, these
results are not conclusive but support further investigation
based on heterogeneity-corrected optimization.
Several studies have investigated the impact of the
AXB algorithm for intensity-modulated radiation ther-
apy, specifically, in nasopharyngeal carcinomas [20],
lung carcinoma [21], and the experimental use of AXB
with a head and neck phantom [22]. Using both AXB
and AAA algorithms, Kan et al. investigated the dose
distributions to numerous PTVs with different pre-
scribed doses and critical organs [20]. The PTVs were
divided into bone, air, and tissue components. They de-
termined that AXB is recommended for IMRT and
RapidArc planning for patients with nasopharyngeal
carcinomas, which have a similar location to the cases
in the present study.
Han et al. studied how AXB functioned for both
intensity-modulated radiation therapy IMRT and
volumetric-modulated arc therapy (VMAT) [22]. They
used a head and neck phantom to calculate dose dis-
tributions for AXB and AAA. Han et al. determined
that there was a good agreement between measured
doses and those calculated with AXB and AAA [22].
AXB findings were equal to or better than those dis-
cerned with film measurements for IMRT and VMAT
plans. Furthermore, they demonstrated that the AXB
calculation time was four times shorter than AAA for
VMAT, which may be important during optimization
of cases with extensive PTV and OAR overlap.
Han and Followill reported the role of the AXB al-
gorithm for heterogeneous dose calculation in lung
cancer [21]. Utilizing a thorax phantom, they showed
that AXB was accurate for dose calculation in lung
cancer for both IMRT and VMAT. In addition, they
determined that AXB may improve accuracy and re-
duce computation time in lung VMAT [21]. The
present study represents the first in the literature that
explored the heterogeneity correction for frameless
IM-SRS in pituitary and cavernous sinus tumors. The
findings of the present study reflect those of previousworks [20–22] in that AXB is beneficial in heteroge-
neous dose corrections.
Conclusions
Patients undergoing frameless SRS benefit from hetero-
geneity corrected dose plans when the lesion lies in areas
of widely varying tissue density and near critical normal
structures. A uniform density algorithm overestimates
the dose to OAR compared with heterogeneity algo-
rithms for patients with OAR and PTV overlap. Further-
more, film dosimetry confirms the AcurosXB dose
calculation algorithm more accurately predicts deposited
dose though tissues of varying densities than PB or AAA
dose calculation algorithms. Our results suggest that pa-
tients undergoing radiosurgery for base of skull lesions
may benefit from AXB calculations when OAR and PTV
overlap during the planning process. However, there are
other algorithms including collapsed cone which was
not studied here. Advanced heterogeneity corrections
should be validated with phantom measurement to
simulate a given clinical scenario.
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